The FDA, the DSM, Gender Equality, and “Female Viagra”

The committee had voted 18-6, in a surprise reversal, to recommend that the organization now approve flibanserin as capable of treating low sexual desire in women. The decision was made even after the APA agreed to drop “Hypoactive Sexual Desire Disorder” in women from DSM-5 after controversy about its validity and setting—the disorder’s definition in Read more

Older Posts